Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis (Q28176385)

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Pharmacologic Control of Thromboembolic Complications of Cardiac-Valve Replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Low-intensity oral anticoagulation plus low-dose aspirin versus high-intensity oral anticoagulation alone: a randomized trial in patients with mechanical prosthetic heart valves.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Formulating questions and locating primary studies for inclusion in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Selecting and appraising studies for a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Estimators of the Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

A comparison of statistical methods for combining event rates from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Cumulative meta-analysis of therapeutic trials for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Meta-analysis in clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

The file drawer problem and tolerance for null results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Language bias in randomised controlled trials published in English and German.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

The hazards of scoring the quality of clinical trials for meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Publication Bias: A Problem in Interpreting Medical Data

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Should unpublished data be included in meta-analyses? Current convictions and controversies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021

Overcoming the limitations of current meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901135-9

7 January 2021